Advances in Immunotherapy for Transplant Oncology
- PMID: 39001431
 - PMCID: PMC11240695
 - DOI: 10.3390/cancers16132369
 
Advances in Immunotherapy for Transplant Oncology
Abstract
The increasing incidence of global cancer rates has created an entirely new demand for curative treatment modalities to improve patient outcomes [...].
Conflict of interest statement
The authors declare no conflicts of interest.
References
- 
    
- Safarpour A.R., Askari H., Ejtehadi F., Azarnezhad A., Raeis-Abdollahi E., Tajbakhsh A., Abazari M.F., Tarkesh F., Shamsaeefar A., Niknam R., et al. Cholangiocarcinoma and liver transplantation: What we know so far? World J. Gastrointest. Pathophysiol. 2021;12:84–105. doi: 10.4291/wjgp.v12.i5.84. - DOI - PMC - PubMed
 
 - 
    
- Abboud K., Umoru G., Esmail A., Abudayyeh A., Murakami N., Al-Shamsi H.O., Javle M., Saharia A., Connor A.A., Kodali S., et al. Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology. Cancers. 2023;15:1433. doi: 10.3390/cancers15051433. - DOI - PMC - PubMed
 
 
Publication types
LinkOut - more resources
Full Text Sources
